The $38 billion U.S. commercial weight loss market is 15% larger than in 2020, but has had to pivot to adjust to huge competition from the popular GLP-1 drugs ... includes a 35-year revenue ...

Abbott Laboratories, a global healthcare giant, develops and markets a broad range of medical devices, diagnostics, branded generic medicines, and nutritional products. Its strong focus on innovation ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

The ‘miracle’ weight ... market for these drugs is valued at ₹576 crore as of February 2025. It has almost quadrupled in the past five years, expanding at a compound annual growth rate ...

Patients, doctors and investors will soon learn a lot more about a new, more convenient treatment that could shake up the booming weight loss drug market ... watched of the year, as they bring ...

Eli Lilly on Thursday launched in India its diabetes and weight-loss drug, Mounjaro, which has already clocked in over $20 ...